Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants.

NCT05958771 is registered in ClinicalTrials.gov with University of Chile as lead sponsor.

NCT NCT05958771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05958771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants.
Lead sponsor
University of Chile
Phase
Phase 3
Overall status
Completed
Start date
July 6, 2023
Completion date
February 27, 2026
Enrollment
4,270 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

rotavirus gastroenteritis